Patent offices worldwide are filled with applications for things that have never seen the light of day
these are areas of investigation, not guaranteed outcomes
But oral supplements only deliver about 20% absorption due to digestive breakdown
Genetic markers, gut microbiome composition, and baseline metabolic rate could help identify which patients benefit most from GLP-1, GLP-1/GIP, GLP-1/GCGR, or GLP-1/GIP/Glucagon agonists
Leal-Lassalle et al., 2025)
The study documented BPC-157's neuroprotective effects in the central nervous system, extending the peptide's documented tissue-protective properties beyond peripheral tissues to include spinal cord repair